Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease.

Phillips RO, Sarfo FS, Landier J, Oldenburg R, Frimpong M, Wansbrough-Jones M, Abass K, Thompson W, Forson M, Fontanet A, Niang F, Demangel C.

PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2786. doi: 10.1371/journal.pntd.0002786. eCollection 2014 Apr.

2.

Mycobacterium ulcerans infection.

van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K.

Lancet. 1999 Sep 18;354(9183):1013-8. Review.

PMID:
10501380
3.

Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.

Niang F, Sarfo FS, Frimpong M, Guenin-Macé L, Wansbrough-Jones M, Stinear T, Phillips RO, Demangel C.

Sci Rep. 2015 Dec 4;5:17693. doi: 10.1038/srep17693.

4.

Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease.

Phillips R, Sarfo FS, Guenin-Macé L, Decalf J, Wansbrough-Jones M, Albert ML, Demangel C.

J Infect Dis. 2009 Dec 1;200(11):1675-84. doi: 10.1086/646615.

PMID:
19863437
5.

Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva.

Marsollier L, Deniaux E, Brodin P, Marot A, Wondje CM, Saint-André JP, Chauty A, Johnson C, Tekaia F, Yeramian E, Legras P, Carbonnelle B, Reysset G, Eyangoh S, Milon G, Cole ST, Aubry J.

PLoS Med. 2007 Feb;4(2):e64.

6.

Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.

Silva MT, Portaels F, Pedrosa J.

Lancet Infect Dis. 2009 Nov;9(11):699-710. doi: 10.1016/S1473-3099(09)70234-8. Review.

PMID:
19850228
7.

Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?

Ruf MT, Chauty A, Adeye A, Ardant MF, Koussemou H, Johnson RC, Pluschke G.

PLoS Negl Trop Dis. 2011 Aug;5(8):e1252. doi: 10.1371/journal.pntd.0001252. Epub 2011 Aug 2.

8.

Distribution of Mycobacterium ulcerans in buruli ulcer endemic and non-endemic aquatic sites in Ghana.

Williamson HR, Benbow ME, Nguyen KD, Beachboard DC, Kimbirauskas RK, McIntosh MD, Quaye C, Ampadu EO, Boakye D, Merritt RW, Small PL.

PLoS Negl Trop Dis. 2008 Mar 26;2(3):e205. doi: 10.1371/journal.pntd.0000205.

9.

Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics.

Pidot SJ, Porter JL, Marsollier L, Chauty A, Migot-Nabias F, Badaut C, Bénard A, Ruf MT, Seemann T, Johnson PD, Davies JK, Jenkin GA, Pluschke G, Stinear TP.

PLoS Negl Trop Dis. 2010 Nov 2;4(11):e872. doi: 10.1371/journal.pntd.0000872.

10.

Epidemiology and management of Buruli ulcer.

Huang GK, Johnson PD.

Expert Rev Anti Infect Ther. 2014 Jul;12(7):855-65. doi: 10.1586/14787210.2014.910113. Review.

PMID:
24918117
11.

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer.

Doig KD, Holt KE, Fyfe JA, Lavender CJ, Eddyani M, Portaels F, Yeboah-Manu D, Pluschke G, Seemann T, Stinear TP.

BMC Genomics. 2012 Jun 19;13:258. doi: 10.1186/1471-2164-13-258.

12.

Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.

Walsh DS, Eyase F, Onyango D, Odindo A, Otieno W, Waitumbi JN, Bulimo WD, Schnabel DC, Meyers WM, Portaels F.

Am J Trop Med Hyg. 2009 Dec;81(6):1110-3. doi: 10.4269/ajtmh.2009.09-0313.

PMID:
19996445
13.

Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Demangel C, Stinear TP, Cole ST.

Nat Rev Microbiol. 2009 Jan;7(1):50-60. doi: 10.1038/nrmicro2077. Review.

PMID:
19079352
14.

Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.

Vincent QB, Ardant MF, Adeye A, Goundote A, Saint-André JP, Cottin J, Kempf M, Agossadou D, Johnson C, Abel L, Marsollier L, Chauty A, Alcaïs A.

Lancet Glob Health. 2014 Jul;2(7):e422-30. doi: 10.1016/S2214-109X(14)70223-2. Epub 2014 Jun 17.

15.

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.

Bolz M, Ruggli N, Borel N, Pluschke G, Ruf MT.

PLoS Negl Trop Dis. 2016 Apr 29;10(4):e0004678. doi: 10.1371/journal.pntd.0004678. eCollection 2016 Apr.

16.

[Mycobacterium ulcerans disease (Buruli ulcer) in Gabon: 2005-2011].

Bayonne Manou LS, Portaels F, Eddyani M, Book AU, Vandelannoote K, de Jong BC.

Med Sante Trop. 2013 Oct-Dec;23(4):450-7. doi: 10.1684/mst.2013.0259. French.

17.

Buruli ulcer (Mycobacterium ulcerans infection).

Walsh DS, Portaels F, Meyers WM.

Trans R Soc Trop Med Hyg. 2008 Oct;102(10):969-78. doi: 10.1016/j.trstmh.2008.06.006. Epub 2008 Jul 26. Review.

PMID:
18657836
18.

Buruli ulcer.

Portaels F, Silva MT, Meyers WM.

Clin Dermatol. 2009 May-Jun;27(3):291-305. doi: 10.1016/j.clindermatol.2008.09.021. Review.

PMID:
19362692
19.

[Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].

En J, Ishii N, Goto M.

Nihon Hansenbyo Gakkai Zasshi. 2011 Feb;80(1):5-10. Review. Japanese.

PMID:
21404590
20.

Ultrasonography for the monitoring of subcutaneous damage in Mycobacterium ulcerans infection (Buruli ulcer).

Leigheb G, Cammarota T, Zavattaro E, Sarno A, Carriero A, Gambaro AC, Dossou A, Poggio F, Clemente C, Johnson RC, Sopoh G, Leigheb F.

Ultrasound Med Biol. 2008 Oct;34(10):1554-63. doi: 10.1016/j.ultrasmedbio.2008.03.010. Epub 2008 Jun 4.

PMID:
18524460

Supplemental Content

Support Center